azacitidine
Onureg, Vidaza · ATC code L01BC07
Also known as: Azacitidin · Brand names: Onureg, Vidaza, Azacitidin Hikma, Azacitidin Sandoz, Azacitidin Stada, Azacitidin Tillomed, Azacitidin Zentiva, Azatidine Aliud, Azadin, Azatu, Azavix, Azida, Vizadis
- Key facts
- Active substance
- azacitidine
- Drug class
- Antimetabolite
- ATC code
- L01BC07
- Authorisation
- centrally authorised across the EU (EMA)
- Dosage forms
- Onureg 200 mg film-coated tablets / Onureg 300 mg film-coated tablets · Vidaza 25 mg/mL powder for suspension for injection
- Marketing authorisation holder
- Bristol-Myers Squibb Pharma EEIG
- Information as of
- 2026-10-27
Key facts
Azacitidine is a pyrimidine analogue (antimetabolite) for certain myeloid neoplasms: as an injection (Vidaza) in MDS, CMML and AML, and as tablets (Onureg) for AML maintenance therapy.
What it is used for
- Vidaza: adults not eligible for stem cell transplantation with intermediate-2 or high-risk MDS (IPSS)
- Vidaza: CMML with 10-29% marrow blasts without myeloproliferative disorder, and AML with 20-30% blasts and multi-lineage dysplasia or with > 30% marrow blasts
- Onureg: maintenance therapy in adults with AML in complete remission (CR/CRi) after induction who are not candidates for stem cell transplantation
Dosing
- Vidaza: 75 mg/m² body surface area subcutaneously daily for 7 days, then 21 days rest (28-day cycle); minimum of 6 cycles recommended
- Vidaza: dose reduction or delay based on nadir blood counts (scheme in full text)
- Onureg: 300 mg orally once daily for 14 days, followed by 14 days off (28-day cycle)
- Onureg: anti-emetic 30 minutes before each dose for the first 2 cycles; reduction to 200 mg possible for neutropenia
- Oral and injectable forms must not be used interchangeably
- Complete blood counts before starting and regularly before cycles
Contraindications
- Hypersensitivity to the active substance or any excipient
- Breast-feeding
- Vidaza: advanced malignant hepatic tumours
Important warnings
- Haematological toxicity (neutropenia, thrombocytopenia, anaemia, febrile neutropenia); fever and bleeding signs should be reported promptly
- Vidaza: progressive hepatic coma and death reported with extensive hepatic tumour burden
- Vidaza: renal abnormalities up to renal failure reported; creatinine and bicarbonate checked before each cycle
- Onureg: more frequent monitoring in moderate and severe hepatic impairment
- Differentiation syndrome possible (details in full text)
Side effects
- Onureg, most common: nausea, vomiting, diarrhoea, neutropenia, fatigue, constipation, thrombocytopenia
- Onureg, serious: febrile neutropenia and pneumonia
- Vidaza: haematological reactions, nausea, vomiting and injection site reactions very frequent
- Vidaza, serious: febrile neutropenia, infections (some fatal), haemorrhage
Interactions
- No formal clinical interaction studies
- Interactions via CYP enzymes are considered unlikely
- Onureg: no dose change needed with proton pump inhibitors; caution with other antineoplastics
Pregnancy and breastfeeding
- Effective contraception for women during and up to 6 months after, for men up to 3 months after treatment
- Breast-feeding is contraindicated
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Package leaflet, verbatim
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
EU – centrally authorised (all member states)
- Azacitidine Accord · genericAccord Healthcare S.L.U. · EMEA/H/C/005147
- Azacitidine betapharm · genericbetapharm Arzneimittel GmbH · EMEA/H/C/005075
- Azacitidine Kabi · genericFresenius Kabi Deutschland GmbH · EMEA/H/C/006154
- Azacitidine Mylan · genericMylan Pharmaceuticals Limited · EMEA/H/C/004984
- OnuregBristol-Myers Squibb Pharma EEIG · EMEA/H/C/004761
- VidazaBristol-Myers Squibb Pharma EEIG · EMEA/H/C/000978
Source: European Medicines Agency (EMA), product information
Austria
- Azacitidin HikmaHikma Farmacêutica (Portugal), S.A. · 1 register entry
- Azacitidin SandozSandoz Gmbh · 2 register entries
- Azacitidin StadaStada Arzneimittel Gmbh · 1 register entry
- Azacitidin TillomedTillomed Pharma Gmbh · 1 register entry
- Azacitidin ZentivaZentiva, K.S. · 1 register entry
- Azatidine AliudAliud Pharma Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- AzacitidinStadapharm Gmbh, Pharmascience International Ltd, Bendalis Gmbh, Seacross Pharma (Europe) Ltd, Tillomed Pharma Gmbh, Onkovis Gmbh, Zentiva Pharma Gmbh, Aqvida Gmbh, Hexal Ag, Hikma Farmacêutica (Portugal), S.A., Eugia Pharma (Malta) Limited, Onko Pharmaceuticals · 13 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- AzadinKOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. · 1 register entry
- AzatuONKO İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- AzavixTEVA İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- AzidaFARMAKO ECZACILIK A.Ş. · 1 register entry
- OnuregBRISTOL-MYERS SQUIBB İLAÇLARI INC. İSTANBUL ŞUBESİ · 4 register entries
- VidazaBRISTOL-MYERS SQUIBB İLAÇLARI INC. İSTANBUL ŞUBESİ · 1 register entry
- VizadisDEVA HOLDİNG A.Ş. · 1 register entry
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 27 more European countries
- Belgium
- Azacitidin Sandoz, Azacitidine Eugia, Azacitidine Eurogenerics, Azacitidine Hikma, Azacitidine Seacross
- Bulgaria
- Азацитидин
- Croatia
- Azacitidin Pharmascience, Azacitidin Sandoz, Azacitidin Stada, Etraga, Zassida
- Cyprus
- Azacitidine Koanaa, Azacitidine Sandoz, Azacitidine Stada
- Czechia
- Azacitidin Sandoz, Azacitidine Rompharm, Azacitidine Zentiva, Rendazvi
- Denmark
- Azacitidin "biogaran", Azacitidin "stada Arzneimittel Ag", Azacitidin Adalvo, Azacitidin Hikma, Azacitidin Sandoz, Azacitidin Stada, Azacitidin Tillomed, Azacitidine "stada", Azacitidine Lotus Pharma Bulgaria, Azacitidine Sandoz, Azacitidine Sun, Azacitidine Zentiva, Etraga, Rendazvi
- Estonia
- Azacitidine Auxilia
- Finland
- Azacitidine Hikma, Azacitidine Sandoz, Azacitidine Stada, Azacitidine Sun, Azacitidine Tillomed
- France
- Azacitidine Arrow, Azacitidine Biogaran, Azacitidine Eg, Azacitidine Ever Pharma, Azacitidine Hikma, Azacitidine Reddy Pharma, Azacitidine Sandoz, Azacitidine Seacross, Azacitidine Tillomed, Azacitidine Vivanta, Azacitidine Zentiva, Famotidine Msn Laboratories Europe Ltd Vivanta Generics S.R.O.
- Greece
- Azacitidine Sandoz, Azacitidine Stada, Azanex, Azida, Rendazvi
- Hungary
- Azacitidin Aliud, Azacitidin Sandoz, Azacitidin Stada Arzneimittel Ag, Azacitidine Oncoeurope, Azacitidine Stada, Azacitidine Zentiva, Etraga, Vidaculem
- Iceland
- Azacitidine Accord, Azacitidine Glenmark, Azacitidine Kabi, Azacitidine Mylan, Azacitidine Stada, Azacitidine Zentiva, Azida, Etraga, Onureg, Vidaza, Zassida
- Ireland
- Azacitdine Clonmel, Azacitidine Clonmel, Azacitidine Rowex, Azacitidine Seacross
- Italy
- Azacitidina Aurobindo, Azacitidina Eg Stada, Azacitidina Hikma, Azacitidina Sandoz, Azacitidina Seacross, Azacitidina Tillomed, Azacitidina Zentiva
- Liechtenstein
- Azacitidine Accord, Azacitidine Kabi, Azacitidine Mylan, Onureg, Vidaza
- Lithuania
- Azacitidine Auxilia, Azacitidine Icg Farma
- Luxembourg
- Azacitidine Eurogenerics
- Malta
- Azacitidine Adalvo, Azacitidine Lotus, Azacitidine Sandoz
- Netherlands
- Azacitidine, Laziros
- Norway
- Azacitidin Sun, Azacitidin Tillomed, Azacitidine Accord, Azacitidine Hikma, Azacitidine Kabi, Azacitidine Mylan, Azacitidine Sandoz, Azacitidine Stada, Azacitidine Zentiva, Etraga, Onureg, Vidaza
- Poland
- Azacitidine Eugia, Azacitidine Msn, Azacitidine Onko, Azacitidine Sandoz, Azacitidine Stada, Etraga
- Portugal
- Azacitidina Eugia, Azacitidina Hikma, Azacitidina Sandoz, Azacitidina Seacross, Azacitidina Zentiva
- Romania
- Azacitidine Zentiva, Azacitidină Aqvida, Azacitidină Dr. Reddy’s, Azacitidină Onko, Azacitidină Rompharm, Azacitidină Sandoz, Azacitidină Stada, Etraga, Laziros, Vidaculem
- Slovakia
- Azacitidine Glenmark, Azacitidine Sandoz, Azacitidine Stada, Azacitidine Zentiva, Zassida
- Slovenia
- Azacitidin Sandoz, Azacitidin Stada, Rendazvi, Vidaculem
- Spain
- Azacitidina Dr. Reddys, Azacitidina Eugia, Azacitidina Hikma, Azacitidina Sandoz, Azacitidina Seacross, Azacitidina Stadafarma, Azacitidina Zentiva
- Sweden
- Azacitidine Azacitidine Lotus Pharma, Azacitidine Hikma, Azacitidine Sandoz, Azacitidine Stada, Azacitidine Sun, Azacitidine Tillomed, Azacitidine Zentiva, Etraga
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- European Medicines Agency. Onureg – EPAR, Product Information (OF THE TEXT Detailed information on this medicinal product i). 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/onureg-epar-product-information_en.pdf
- European Medicines Agency. Vidaza – EPAR, Product Information (OF THE TEXT Detailed information on this medicinal product i). 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/vidaza-epar-product-information_en.pdf
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- Wikidata (CC0): ATC L01BC.
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: European Medicines Agency (EMA), product information. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.